Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
(equivalence trial)
892 results
  • Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. [Randomized Controlled Trial]
    N Engl J Med 2019; 381(12):1103-1113Yasuda S, Kaikita K, … AFIRE Investigators
  • CONCLUSIONS: As antithrombotic therapy, rivaroxaban monotherapy was noninferior to combination therapy for efficacy and superior for safety in patients with atrial fibrillation and stable coronary artery disease. (Funded by the Japan Cardiovascular Research Foundation; AFIRE UMIN Clinical Trials Registry number, UMIN000016612; and ClinicalTrials.gov number, NCT02642419.).
  • [Moderate or extreme hypofractionation and localized prostate cancer: The times are changing]. [Review]
    Cancer Radiother 2019; 23(6-7):503-509Line Krhili S, Créhange G, … Supiot S
  • There are many treatment options for localized prostate cancers, including active surveillance, brachytherapy, external beam radiotherapy, and radical prostatectomy. Quality of life remains a primary objective in the absence of superiority of one strategy over another in terms of specific survival with similar long-term biochemical control rates. Despite a significant decrease in digestive and ur…
New Search Next